246 related articles for article (PubMed ID: 31152494)
1. Transient introduction of human telomerase mRNA improves hallmarks of progeria cells.
Li Y; Zhou G; Bruno IG; Zhang N; Sho S; Tedone E; Lai TP; Cooke JP; Shay JW
Aging Cell; 2019 Aug; 18(4):e12979. PubMed ID: 31152494
[TBL] [Abstract][Full Text] [Related]
2. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
3. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
[TBL] [Abstract][Full Text] [Related]
4. Establishment and Characterization of
Lin H; Mensch J; Haschke M; Jäger K; Köttgen B; Dernedde J; Orsó E; Walter M
Cells; 2022 Sep; 11(18):. PubMed ID: 36139359
[TBL] [Abstract][Full Text] [Related]
5. Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells.
Arnold R; Vehns E; Randl H; Djabali K
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299092
[TBL] [Abstract][Full Text] [Related]
6. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome.
Wheaton K; Campuzano D; Ma W; Sheinis M; Ho B; Brown GW; Benchimol S
Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483909
[TBL] [Abstract][Full Text] [Related]
7. Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence.
Benson EK; Lee SW; Aaronson SA
J Cell Sci; 2010 Aug; 123(Pt 15):2605-12. PubMed ID: 20605919
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
[TBL] [Abstract][Full Text] [Related]
9. Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.
Matrone G; Thandavarayan RA; Walther BK; Meng S; Mojiri A; Cooke JP
Cell Cycle; 2019 Oct; 18(19):2495-2508. PubMed ID: 31411525
[TBL] [Abstract][Full Text] [Related]
10. Telomerase therapy reverses vascular senescence and extends lifespan in progeria mice.
Mojiri A; Walther BK; Jiang C; Matrone G; Holgate R; Xu Q; Morales E; Wang G; Gu J; Wang R; Cooke JP
Eur Heart J; 2021 Nov; 42(42):4352-4369. PubMed ID: 34389865
[TBL] [Abstract][Full Text] [Related]
11. Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts.
Bikkul MU; Clements CS; Godwin LS; Goldberg MW; Kill IR; Bridger JM
Biogerontology; 2018 Dec; 19(6):579-602. PubMed ID: 29907918
[TBL] [Abstract][Full Text] [Related]
12. Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria.
Chojnowski A; Ong PF; Wong ES; Lim JS; Mutalif RA; Navasankari R; Dutta B; Yang H; Liow YY; Sze SK; Boudier T; Wright GD; Colman A; Burke B; Stewart CL; Dreesen O
Elife; 2015 Aug; 4():. PubMed ID: 26312502
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.
Gabriel D; Roedl D; Gordon LB; Djabali K
Aging Cell; 2015 Feb; 14(1):78-91. PubMed ID: 25510262
[TBL] [Abstract][Full Text] [Related]
14. Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome.
Wang Y; Ostlund C; Worman HJ
Nucleus; 2010; 1(5):432-9. PubMed ID: 21326826
[TBL] [Abstract][Full Text] [Related]
15. Telomere elongation through hTERT immortalization leads to chromosome repositioning in control cells and genomic instability in Hutchinson-Gilford progeria syndrome fibroblasts, expressing a novel SUN1 isoform.
Bikkul MU; Faragher RGA; Worthington G; Meinke P; Kerr ARW; Sammy A; Riyahi K; Horton D; Schirmer EC; Hubank M; Kill IR; Anderson RM; Slijepcevic P; Makarov E; Bridger JM
Genes Chromosomes Cancer; 2019 Jun; 58(6):341-356. PubMed ID: 30474255
[TBL] [Abstract][Full Text] [Related]
16. Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53.
Kudlow BA; Stanfel MN; Burtner CR; Johnston ED; Kennedy BK
Mol Biol Cell; 2008 Dec; 19(12):5238-48. PubMed ID: 18843043
[TBL] [Abstract][Full Text] [Related]
17. Genetic and pharmacological modulation of lamin A farnesylation determines its function and turnover.
Foo MXR; Ong PF; Yap ZX; Maric M; Bong CJS; Dröge P; Burke B; Dreesen O
Aging Cell; 2024 May; 23(5):e14105. PubMed ID: 38504487
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson-Gilford Progeria Syndrome.
Aguado J; Sola-Carvajal A; Cancila V; Revêchon G; Ong PF; Jones-Weinert CW; Wallén Arzt E; Lattanzi G; Dreesen O; Tripodo C; Rossiello F; Eriksson M; d'Adda di Fagagna F
Nat Commun; 2019 Nov; 10(1):4990. PubMed ID: 31740672
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome.
Gordon LB; Kleinman ME; Miller DT; Neuberg DS; Giobbie-Hurder A; Gerhard-Herman M; Smoot LB; Gordon CM; Cleveland R; Snyder BD; Fligor B; Bishop WR; Statkevich P; Regen A; Sonis A; Riley S; Ploski C; Correia A; Quinn N; Ullrich NJ; Nazarian A; Liang MG; Huh SY; Schwartzman A; Kieran MW
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16666-71. PubMed ID: 23012407
[TBL] [Abstract][Full Text] [Related]
20. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
